Search hospitals > New Mexico > Albuquerque
University of New Mexico Health Sciences Center
Claim this profileAlbuquerque, New Mexico 87102
Global Leader in Coronavirus
Global Leader in High Blood Pressure
Conducts research for Pulmonary Arterial Hypertension
Conducts research for COVID-19
Conducts research for Infections
94 reported clinical trials
10 medical researchers
Summary
University of New Mexico Health Sciences Center is a medical facility located in Albuquerque, New Mexico. This center is recognized for care of Coronavirus, High Blood Pressure, Pulmonary Arterial Hypertension, COVID-19, Infections and other specialties. University of New Mexico Health Sciences Center is involved with conducting 94 clinical trials across 218 conditions. There are 10 research doctors associated with this hospital, such as Davin Quinn, MD, Andrew Carlson, MD, Michel Torbey, MD, and Joao P Teixeira, MD.Area of expertise
1Coronavirus
Global LeaderSARS-CoV-2
SARSCo2
RT-PCR
2High Blood Pressure
Global LeaderTop PIs
Davin Quinn, MDUniversity of New Mexico1 year of reported clinical research
Studies Post-Traumatic Stress Disorder
Studies Traumatic Brain Injury
6 reported clinical trials
8 drugs studied
Andrew Carlson, MDUniversity of New Mexico Hospital2 years of reported clinical research
Studies Normal Pressure Hydrocephalus
Studies Hydrocephalus
3 reported clinical trials
5 drugs studied
Michel Torbey, MDThe University of New Mexico - School of Medicine14 years of reported clinical research
Studies Ischemic Stroke
Studies Stroke
3 reported clinical trials
2 drugs studied
Joao P Teixeira, MDUniversity of New Mexico Health Sciences Center1 year of reported clinical research
Studies Septic Shock
Studies Shock
2 reported clinical trials
2 drugs studied
Clinical Trials running at University of New Mexico Health Sciences Center
Pulmonary Arterial Hypertension
High Blood Pressure
Pulmonary Hypertension
Spinal Cord Injury
Coronavirus
Brain Arteriovenous Malformation
Heart Failure
Septic Shock
Opioid Overdose
Spinal Fracture
Sotatercept
for Pulmonary Arterial Hypertension
This trial is testing sotatercept, a medication for high blood pressure in the lungs, in adults with PAH who have completed earlier studies. It aims to see if the medication is safe and effective over a long period. Sotatercept helps lung blood vessels function better, reducing lung pressure. Sotatercept has shown promising results in earlier studies for reducing lung pressure and improving exercise tolerance in patients with pulmonary arterial hypertension (PAH).
Recruiting2 awards Phase 39 criteria
Seralutinib
for Pulmonary Arterial Hypertension
This trial is testing a medication called seralutinib to see if it can help people with a specific type of lung disease (PAH) improve their ability to exercise. The medication works by blocking signals that cause the blood vessels in the lungs to tighten and narrow. Seralutinib is delivered via inhalation and is being developed for patients with pulmonary arterial hypertension. The goal is to see if this can reduce lung pressure and delay worsening of the disease.
Recruiting1 award Phase 313 criteria
Sotatercept
for Pulmonary Arterial Hypertension
This trial is testing sotatercept, a new medication, to see if it can help people with a specific type of high blood pressure in the lungs (PAH) when added to their usual treatment. The study focuses on patients who are newly diagnosed and at higher risk of their condition worsening. Sotatercept aims to reduce the pressure in the lung's blood vessels, potentially slowing down disease progression. Sotatercept has shown significant reduction in pulmonary vascular resistance and maintained clinical efficacy in previous studies.
Recruiting1 award Phase 310 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at University of New Mexico Health Sciences Center?
University of New Mexico Health Sciences Center is a medical facility located in Albuquerque, New Mexico. This center is recognized for care of Coronavirus, High Blood Pressure, Pulmonary Arterial Hypertension, COVID-19, Infections and other specialties. University of New Mexico Health Sciences Center is involved with conducting 94 clinical trials across 218 conditions. There are 10 research doctors associated with this hospital, such as Davin Quinn, MD, Andrew Carlson, MD, Michel Torbey, MD, and Joao P Teixeira, MD.